Latest Morning Briefing Stories
Opinion writers weigh in on these pandemic topics and others.
The future of those and other key health care issues hinge on the outcome of November’s elections: Democratic presidential nominee Joe Biden and President Donald Trump are reinforcing that point to voters on the campaign trail.
On Saturday, 1,061,411 COVID-19 diagnostic tests were performed in the U.S., according to The COVID Tracking Project.
All health agencies that fall under the Department of Health and Human Services umbrella can no longer issue their own regulatory actions related to foods, medicines, medical devices and vaccines, according to a memo from HHS Secretary Alex Azar obtained by The New York Times.
A former member of the University of Notre Dame’s “Faculty for Life,” Amy Coney Barrett signed a 2015 letter to Catholic bishops that affirmed the “teachings of the Church as truth.” Among those teachings: the “value of human life from conception to natural death.” Liberals have interpreted that as a threat to the 1973 Roe v. Wade decision legalizing abortion nationwide.
The latest forecast from President Donald Trump came Friday when he said, “I think distribution will go even quicker than most people think.” Complex logistics challenge that timeline, public health and vaccine experts say.
The previous phrasing suggested asymptomatic people did not need a test. That phrasing sparked strong criticism from public health experts and has since been revealed to have been shaped by political appointees, not scientists.
A new case challenging the constitutionality of the Affordable Care Act is due to be heard at the Supreme Court in November. News outlets look at how a new court composition, following the death of Supreme Court Justice Ruth Bader Ginsburg on Friday, could impact that health law case or future ones.
In the absence of Ruth Bader Ginsburg from the Supreme Court bench, Roe v. Wade is expected to again be contested and as well as other state restrictions on the procedure. The issue is expected to dominate the debate over her replacement.
The unique nature and timing of the coronavirus crisis gripping the world leaves grieving families and communities to mourn in isolation while government officials struggle to contain the pandemic, especially during an election year. And new cases are again on the rise.
Media outlets report on news from California, Texas, South Dakota, New York, Idaho, Oregon, Louisiana, Colorado and District of Columbia.
All of the cyberattacks, which also targeted Allina Health and Regions Hospital in Minnesota, were part of a ransomware attack on a cloud computing company called Blackbaud.
The big questions persist: How did it start? How will it end? What went wrong? What other viruses are emerging?
In a letter Wednesday, 11 state officials asked the company to “responsibly commit to being a part of our nation’s recovery from COVID-19, both medically and economically, by repricing this drug more affordably.”
Rep. Andy Harris (R-Md.) is on the data and safety monitoring committee for the drug aviptadil. The five-term congressman’s membership on the board is unusual; former FDA chief Scott Gottlieb told Politico he hadn’t heard of a member of Congress sitting on such a committee for any drug. Surgeon General Jerome Adams and Dr. Anthony Fauci also make headlines.
Supply-chain glitches have yet to be fixed. On Thursday, Sen. Chris Murphy (D-Conn.) said the country should “err on the side of saving lives” by federalizing the supply chain.
Companies typically share these plans after studies are complete, but both companies hope to earn the trust of the public and scientists.
The commission, announced by the Centers for Medicare & Medicaid Services in April, was tasked with enhancing strategies for infection control and prevention in facilities. The task force was made up of 25 appointed members, including infectious disease experts and directors of nursing homes. Critics claim it does little to set higher standards.
“The prices are so high, the prices are so unaffordable — it’s just a runaway train,” said Gloria Sachdev, the chief executive of the Employers’ Forum of Indiana, a coalition that worked with RAND on the study.
At a campaign town hall in Pennsylvania, Democratic presidential nominee Joe Biden charged that President Donald Trump’s coronavirus actions have been solely motivated by re-election and financial self-interest. He also questioned vaccine timing talk and slammed Attorney William Barr’s comments comparing pandemic restrictions to slavery.